arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

LifeStance Health Group, Inc.

LFST Health Care Medical/Nursing Services
$12.73
Today
as of Sep 4, 16:51 ET
Last 30 days +13.26% Jul 28 → Sep 04
$10.05 $10.81 $11.58 $12.34 $13.10 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$12.85
High
$12.98
Low
$12.54
Volume
$2M
Avg Vol
$3M
Mkt Cap
$4.7B
P/E (TTM)
—
Beta
—
52w High
$13.15
52w Low
$4.77
Div Yield
—
Shares Out
$382M

Recent Press Releases & News last 60 days · 25 items

Sep 5 · 19:05 Simply Wall St.
LifeStance Health Group (LFST) Has Rallied Sharply, Is The Stock Still Undervalued?
Sep 5 · 17:06 Simply Wall St.
LifeStance Health Group (LFST) Stock May Be Above Fair Value On Its 137% Run
Sep 4 · 20:58 MT Newswires
Lifestance Health Group Insider Sold Shares Worth $541,402, According to a Recent SEC Filing
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$4.77
$13
95% of range
Avg surprise (last 3)
+155.6%
Avg reaction (last 2)
+2.2%
50% positive
Latest IV / EM
44%
EM ±6.9% · $13 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.54$-0.27$0.00$0.27$0.54 Est $-0.04Actual $-0.01Est $-0.03Actual $0.04Est $0.01 Mar/2025Jun/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-4M$111M$227M$342M$457M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $0.04 $0.01 +300.0% — +20.2% earnings
Thu Aug 7, 2025Jun/2025 $-0.01 $-0.03 +66.7% — — earnings
Wed May 7, 2025Mar/2025 — $-0.04 +100.0% — -15.9% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$435M$403M—$364M$345M$333M—$313M
Cost of revenue————————
Gross profit————————
Operating income$31M$22M—$7M$-3M$2M—$47,000
Net income$24M$14M—$1M$-4M$709,000—$709,000
EPS (diluted)————————

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$226M$195M$249M$204M$189M$134M$155M$103M
Inventory————————
Total current assets$378M$356M$416M$360M$359M$305M$313M$287M
Total assets$2.18B$2.15B$2.20B$2.15B$2.15B$2.10B$2.12B$2.11B
Long-term debt$259M$262M$266M$269M$273M$276M$280M$279M
Total liabilities$704M$668M$683M$656M$673M$648M$672M$671M
Total equity$1.48B$1.48B$1.52B$1.49B$1.47B$1.46B$1.45B$1.44B

Implied volatility — last 90 days

32%70%108%146%184% Jun 07 — IV 107% · EM ±14.8%Jun 08 — IV 120% · EM ±15.9%Jun 09 — IV 141% · EM ±17.6%Jun 10 — IV 59% · EM ±7.0%Jun 11 — IV 184% · EM ±20.3%Jun 12 — IV 131% · EM ±13.4%Jun 15 — IV 161% · EM ±11.6%Jun 16 — IV 179% · EM ±10.6%Jun 19 — IV 40% · EM ±8.9%Jun 22 — IV 62% · EM ±12.9%Jun 23 — IV 45% · EM ±9.2%Jun 24 — IV 41% · EM ±8.3%Jun 25 — IV 39% · EM ±7.6%Jun 26 — IV 42% · EM ±8.0%Jun 29 — IV 43% · EM ±7.6%Jun 30 — IV 45% · EM ±7.7%Jul 01 — IV 43% · EM ±7.2%Jul 02 — IV 43% · EM ±6.9%Jul 03 — IV 44% · EM ±6.9%Jul 06 — IV 39% · EM ±5.5%Jul 07 — IV 36% · EM ±4.8%Jul 08 — IV 65% · EM ±8.1%Jul 09 — IV 47% · EM ±5.6%Jul 10 — IV 38% · EM ±4.2%Jul 13 — IV 39% · EM ±3.2%Jul 14 — IV 32% · EM ±2.3%Jul 15 — IV 54% · EM ±3.2%Jul 16 — IV 75% · EM ±3.1%Jul 20 — IV 68% · EM ±16.1%Jul 21 — IV 101% · EM ±23.6%Jul 22 — IV 62% · EM ±14.1%Jul 23 — IV 79% · EM ±17.9%Jul 24 — IV 88% · EM ±19.5%Jul 27 — IV 64% · EM ±13.3%Jul 28 — IV 91% · EM ±18.7%Jul 29 — IV 94% · EM ±18.9%Jul 30 — IV 69% · EM ±13.5%Jul 31 — IV 107% · EM ±20.5%Aug 03 — IV 72% · EM ±12.8%Aug 04 — IV 93% · EM ±16.1%Aug 05 — IV 69% · EM ±11.6%Aug 06 — IV 75% · EM ±12.2%Aug 07 — IV 59% · EM ±9.2%Aug 10 — IV 73% · EM ±10.1%Aug 11 — IV 105% · EM ±13.9%Aug 12 — IV 55% · EM ±7.0%Aug 13 — IV 48% · EM ±5.7%Aug 14 — IV 91% · EM ±10.1%Aug 17 — IV 86% · EM ±7.2%Aug 18 — IV 89% · EM ±6.5%Aug 19 — IV 109% · EM ±6.4%Aug 20 — IV 142% · EM ±5.9%Aug 24 — IV 46% · EM ±9.6%Aug 25 — IV 52% · EM ±10.6%Aug 26 — IV 42% · EM ±8.4%Aug 27 — IV 45% · EM ±8.7%Aug 28 — IV 34% · EM ±6.5%Aug 31 — IV 41% · EM ±7.3%Sep 01 — IV 53% · EM ±9.1%Sep 02 — IV 39% · EM ±6.6%Sep 03 — IV 41% · EM ±6.6%Sep 04 — IV 44% · EM ±6.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in